9
report
Targeting Tau — Our Hope to Solving the Dementia Crisis
In our systems-based review of the biomedical landscape supporting research of a cellular protein c
alled tau—a common culprit in a number of neurodegenerative diseases—we make the case that focused strategic investment in tau research and the , At present, no disease-modifying therapies for the pure tauopathies exist. Researchers are working to develop effective therapeutic agents, which include approaches such as decreasing the amount of tau within the brain., Symptomatic Interventions
At present, no disease-modifying therapies for the pure tauopathies exist.
+ Read More
report
Misophonia - A Giving Smarter Guide
report
Amyotrophic Lateral Sclerosis (ALS) A Giving Smarter Guide
ALS, commonly known as Lou Gehrig’s disease or motor neurone disease (MND), is a cruel disease that
has challenged patients, their families, and the medical community for generations.
+ Read More
video
Giving Smarter in the Age of COVID-19.
October 20 at 9:00 am PDT/12:00 pm EDT
video
Racial Equity: Philanthropy in Reconciliation and Healing.
October 13 at 1:30 pm PDT/4:30 pm EDT
article
Researchers Invited to Apply for Funding for Basic Science in Sarcoidosis
The Milken Institute Center for Strategic Philanthropy, in partnership with the Ann Theodore Foundat
ion (ATF), is pleased to announce a new Request for Proposals (RFP) focused on understanding the underlying biology of sarcoidosis, an immune dysregulati
+ Read More
article
Global Platform Launches to Transform Bipolar Disorder Research and Care
BD2 commits to finding answers for the 40 million individuals with bipolar disorder and those not ye
t diagnosed
+ Read More
article
Center for Strategic Philanthropy: Summer/Fall 2022 Newsletter
In This Newsletter
Reports and Resources
Program Updates
CSP and Partners in the News
article
October 2020: An Update from the Center for Strategic Philanthropy
In this issue
New Publications and Resources »
Advisory Board »